Evidence map›Paper›PMID 27195607›Full record

ArticlePathogens and global health2016

Human coronavirus and severe acute respiratory infection in Southern Brazil.

Hygor Trombetta, Heloisa Z Faggion, Jaqueline Leotte, Meri B Nogueira, Luine R R Vidal, Sonia M Raboni

Open access · greenAbstract readComment
In one paragraph

Article in Pathogens and global health, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Risk factors for disease progression in patients with mild to moderate coronavirus disease 2019-a multi-centre observational study.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2020
    Observational
  15. Article
  16. Review
  17. SARS-CoV-2: fear versus data.International journal of antimicrobial agents · 2020
    Article
  18. The 2019 coronavirus: Learning curves, lessons, and the weakest link.International journal of clinical practice · 2020
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Hygor Trombettaa Division of Infectious Diseases , Universidade Federal do Paraná , Curitiba , Brazil.
Heloisa Z Faggiona Division of Infectious Diseases , Universidade Federal do Paraná , Curitiba , Brazil.
Jaqueline Leottea Division of Infectious Diseases , Universidade Federal do Paraná , Curitiba , Brazil.
Meri B Nogueirab Laboratory of Virology , Universidade Federal do Paraná , Curitiba , Brazil.
Luine R R Vidalb Laboratory of Virology , Universidade Federal do Paraná , Curitiba , Brazil.
Sonia M Rabonia Division of Infectious Diseases , Universidade Federal do Paraná , Curitiba , Brazil.
Universidade Federal do Paraná · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human coronaviruses (HCoVs) are an important cause of respiratory tract infection and are responsible for causing the common cold in the general population. Thus, adequate surveillance of HCoV is essential. This study aimed to analyze the impact of HCoV infections and their relation to severe acute respiratory infection (SARI) in a hospitalized population in Southern Brazil. A cross-sectional study was conducted at a tertiary care hospital, and assessed inpatients under investigation for SARI by the hospital epidemiology department, and all patients who had nasopharyngeal aspirates collected from January 2012 to December 2013 to detect respiratory viruses (RVs). Viral infection was detected by multiplex reverse transcriptase polymerase chain reaction (RT-PCR), with primers specific to the subtypes HCoV-229E/NL63 and OC43/HKU1. The overall positivity rate was 58.8% (444/755), and HCoVs were detected in 7.6% (n = 34) of positive samples. Children below two years of age were most frequently affected (62%). Comorbidities were more likely to be associated with HCoVs than with other RVs. Immunosuppression was an independent risk factor for HCoV infection (OR = 3.5, 95% CI 1.6-7.6). Dyspnea was less frequently associated with HCoV infection (p < 0.001), and HCoV accounted for 6% of the SARI cases. Three patients infected with HCoV (9%) died from respiratory infection. HCoVs are important respiratory pathogens, especially in hospitalized children under 2 years of age and in immunosuppressed patients. They may account for a small proportion of SARI diagnoses, increased need for mechanical ventilation, intensive care unit admission, and death.

Indexed as

BrazilCoronavirusCoronavirus InfectionsCross-Sectional StudiesHumansInfantRespiratory Tract InfectionsReverse Transcriptase Polymerase Chain ReactionEpidemiologyHuman CoronavirusRespiratory infectionsRT-PCR multiplexSevere acute respiratory infection

Identifiers

PMID27195607
PMCPMC4984956
OpenAlexW2395982709

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.